Advertisement

Canadian Journal of Anesthesia

, Volume 50, Supplement 1, pp R55–R59 | Cite as

Management of the chronic-pain patient in an acute-pain service

  • Brian Knight
Refresher Course Outline Refresher Course 8

Keywords

Morphine Clonidine Dexmedetomidine Oxycodone Fentanyl Patch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    College of Physicians and Surgeons of Alberta. Management of chronic non-malignant pain. http://www.cpsa.ab.ca/publicationsresources/policies.aspGoogle Scholar
  2. 2.
    Canadian Pain Society. Use of opioid analgesics for the treatment of chronic non-cancer pain-A consensus statement and guidelines. http://www.pulsus.com/Pain/03_04/opio_ed.htmGoogle Scholar
  3. 3.
    Allan I, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 12: 322: 1154–8.Google Scholar
  4. 4.
    Jadad AR, Carroll D, Glynn CJ, Moore RA, McQuay HJ. Morphine Responsiveness of Chronic Pain: double blind cross-over study with patient controlled analgesia. Lancet 1992; 339: 1367–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Moulin DE, Iezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non cancer pain. Lancet 1996; 347: 143–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Darke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995; 62: 169–78.PubMedCrossRefGoogle Scholar
  7. 7.
    Mao J, Sung B, Ji RR, Lint G. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 2002; 22: 8312–23.PubMedGoogle Scholar
  8. 8.
    Mao J, Sung B, Ji RR, Lint G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002; 22: 7650–61.PubMedGoogle Scholar
  9. 9.
    Gardell LR, Wang R, Burgess SE, et al. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci 2002; 22: 6747–55.PubMedGoogle Scholar
  10. 10.
    Mao J, Mayer DJ. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Ann N Y Acad Sci 2001; 933: 175–84.PubMedCrossRefGoogle Scholar
  11. 11.
    Lee NM, Smith AP. Opioid receptor polymorphism and opioid abuse, Pharmacogenomics 2002; 3: 219–27.PubMedCrossRefGoogle Scholar
  12. 12.
    Hewitt D. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 2000; 16(2 Suppl): S73–9.PubMedGoogle Scholar
  13. 13.
    Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 1997; 3: 151–7.CrossRefGoogle Scholar
  14. 14.
    Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in post operative pain management: a qualitative review.Google Scholar
  15. 15.
    Khan ZP, Ferguson CN, Jones RM. Alpha 2 and inidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999; 54: 146–65.PubMedCrossRefGoogle Scholar
  16. 16.
    De Kock M, Lavand’homme P, Waterloos H. Balanced analgesia’ in the perioperative period: is there a place for ketamine? Pain 2001; 92: 373–80.PubMedCrossRefGoogle Scholar
  17. 17.
    Gonzalez P, Cabello P, Germany A, Norris B, Contreras E. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur J Pharmacol 1997; 332: 257–62.PubMedCrossRefGoogle Scholar
  18. 18.
    Murdoch CJ, Crooks BA, Miller CD. Effect of the addition of ketamine to morphine in patient-controlled analgesia. Anaesthesia 2002; 57: 484–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. Pain Symptom Manage 2000; 20: 246–52.CrossRefGoogle Scholar
  20. 20.
    Haller G, Waeber JL, Infante NK, Clergue F. Ketamine combined with morphine for the management of pain in an opioid addict. Anesthesiology 2002; 96: 1265–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Park J, Forrest J, Kolesar R, Bhola D, Beattie S, Chu C. Oral clonidine reduces postoperative PCA morphine requirements. Can J Anaesth 1996; 43: 900–6.PubMedCrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists 2003

Authors and Affiliations

  1. 1.Department of Anesthesiology and Pain MedicineUniversity of Alberta HospitalsEdmontonCanada

Personalised recommendations